NCT05061238

Impact Of Muscle Vibration On Gait Control

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 6 Years – 39 Years
• Healthy volunteers: Not accepted

Summary

This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of neuropathy will be documented and assessed by physical therapy, occupational therapy and based on self-reported activities of daily living (ADL) impairment.

Detailed description

Primary Objective: To assess the effect of a vibrating device applied to selected muscles on the step Secondary Objectives: * To summarize the adverse events of different levels from using the vibrator device in oncologic AYA patients visiting the outpatient clinic. * To summarize the irritation, pain, and sensation of the application of vibration by the AYA patients, as determined by the survey during the application

Conditions

• Muscle

Interventions

Type	Name	Description
DEVICE	Vibrating Device	The vibrating device strapped to different parts of your leg. The device will be secured to your leg with a Velcro strap.

Timeline

• Start date: 2021-10-04
• Primary completion: 2027-12-31
• Completion: 2027-12-31
• First posted: 2021-09-29
• Last updated: 2025-12-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study